Over 7.9 mn Covid-19 vaccine doses available with states/UTs: Centre

India is wrestling with a spike in Covid cases in recent weeks

Coronavirus vaccine, Covid-19 vaccine, Covid vaccine
Photo: Shutterstock
Press Trust of India New Delhi
2 min read Last Updated : May 01 2021 | 2:38 PM IST

More than 79 lakh (7.9 million) COVID-19 vaccine doses are available with the states and Union territories and over 17 lakh doses will be supplied to them in the next three days, the Union health ministry said on Saturday.

The Centre has so far provided nearly 16.37 crore vaccine doses to states/UTs free of cost. Of this, the total consumption, including wastages, is 15,58,48,782 doses, according to official data available till 8 am on Saturday.

"More than 79,13,518 COVID-19 vaccine doses are still available with the states and UTs to be administered.

Furthermore, more than 17,31,110 vaccine doses will be received in addition by the states/UTs within the next 3 days," the ministry said.

The ministry also said that Maharashtra has been allocated 17,50,620 Covishield' and 5,76,890 Covaxin' vaccine doses by the Centre for the first fortnight of May.

Delhi has been allocated 3,73,760 Covishield and 1,23,170 Covaxin doses for the same period, it said.

While Chhattisgarh has been allocated 6,47,300 Covishield and 2,13,300 Covaxin doses, West Bengal has been supplied with 9,95,300 Covishield and 3,27,980 Covaxin doses, for the first fortnight of May.

Uttar Pradesh has been allocated 13,49,850 Covishield and 4,11,870 Covaxin doses, and Rajasthan 12,92,460 Covishield and 4,42,390 Covaxin doses, for the same period, the ministry said.

Kerala has been allocated 6,84,070 Covishield and 2,25,430 Covaxin doses, Punjab 4,63,710 Covishield and 1,52,810 Covaxin doses, and Gujarat supplied with 12,48,700 Covishield and 4,11,490 Covaxin doses, for the first fortnight of May, it added.

The central government has been at the forefront of the fight against the COVID-19 pandemic. Vaccination forms an integral component of the five-point strategy of the government to fight the pandemic, including test, track, treat and COVID appropriate behaviour.

Meanwhile, the Liberalised and Accelerated Phase 3 Strategy of COVID-19 Vaccination will be implemented from Saturday. Registration for the new eligible population groups has commenced since April 28.

Potential beneficiaries can either register directly on CoWIN portal or through the Aarogya Setu mobile application, the ministry added.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 01 2021 | 2:27 PM IST

Next Story